希玛医疗控股有限公司（股票代码：03309）于2026年7月23日公告透露，公司于当日于香港联交所场内回购16万股普通股，回购占相关事件前已发行股本（不包括库藏股）约0.0132%。本次回购每股价格区间为0.94港元至0.96港元，合计耗资约15.15万港元。
本次回购完成后，公司已发行股份数量变更为1,208,978,870股，库藏股数量增至23,364,000股，已发行股本总数（包括库藏股）维持在1,232,342,870股。回购授权由公司于2026年5月20日通过，现剩余可回购股份总数为123,234,287股。公司表示，已遵守香港联合交易所有限公司主板上市规则及相关法规的规定。
本次公告由公司秘书陈华平签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.